Our dogs can offer us more than just companionship - they have an incredible ability to detect a range of illnesses in humans ...

This insightful interactive webinar delves into the motor and non-motor symptoms experienced by patients with Parkinson’s ...

Ketamine disrupts abnormal brain activity, offering long-term relief for Parkinson’s dyskinesia in early clinical trials.

This free half-day event will feature three panels of subject matter experts discussing the latest advancements in ...

“Identifying reliable biomarkers for Parkinson’s disease is essential to unlocking earlier diagnosis and more effective treatments. Grifols’ research on a plasma-based biomarker to detect PD ...

A new study has identified polyphosphate as a likely "mystery density" within fibrils associated with Alzheimer's and other ...

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...

A new treatment is now available for people who have certain Parkinson’s Disease symptoms including medication-resistant ...

Regenerative medicine is an exciting field, capable of tackling inherent challenges seen with current therapies.

"Parkinson's is complex and devastating, with no disease-modifying treatment options available for the millions of people impacted," commented Levi Garraway, Roche's chief medical officer and head ...